PPT-New Advances for NAFLD/NASH

New Advances for NAFLDNASH NAFLD A Spectrum of Disease Who Is at Risk for NAFLD and NASH Prevalence of NAFLD in Europe Prevalence of NAFLD and NASH Predicted to Increase in Europe What Is the Burden of NAFLD in Europe. NAFLD. Hepatic . Manifestation of Metabolic Syndrome. a. NAFLD (cont). Hepatic . Manifestation of Metabolic Syndrome. a. NAFLD/NASH Closely Associated With Visceral Obesity, Insulin Resistance. AASLD. Prof. Sandeep Garg. Department of Medicine. Maulana Azad Medical College. New Delhi. INDIA. INTRODUCTION. Non-alcoholic fatty liver disease (NAFLD) - most common cause of chronic liver disease in developed countries (prevalence of 20–30% in the adult population).. Renato. . Paes. . Leme. . Éva. . Tardos. Cornell. Cornell & MSR. Keyword Auctions. organic search results. sponsored search links. Keyword Auctions. Keyword Auctions. Selling one Ad Slot. non-alcoholic fatty liver disease. Dr. . Abdulwahhab. S. Abdullah. CABM, FICMS-G&H. Alcoholic liver . disease. Alcoholic liver . disease (ALD) is . one of the most common causes of . chronic liver disease worldwide.. RSHom. (NA) CCH PCH. NASH. Started in 1990 by Lou Klein, Eric . Sommer. & Val . Ohanian. Original purposes:. Set standards of competency. Certify homeopaths. Advocate for legality. Develop national recognition for homeopathy. Disease. . s_khalilzadeh. A Novel. Cardiometabolic Risk Factor for Type 2 Diabetes. NAFLD and T2DM. NAFLD is closely associated with features of the metabolic. syndrome and is regarded as the hepatic manifestation. adults. Dr.mousavi. -Abadan-. Khordad. 1397 . DEFINITIONS — Patients with nonalcoholic fatty liver disease (NAFLD) . have hepatic . steatosis. , . with or without . inflammation and fibrosis. . In addition, . Sezione di Gastroenterologia e Epatologia, . Di.Bi.M.I.S.,University of Palermo, Italy. salvatore.petta@unipa.it; petsa@inwind.it. William Alazawi MA(. Cantab. ) PhD MRCP. Senior Lecturer and Consultant in . Hepatology. Queen Mary, University of London. Does Liver Disease Matter?. Mortality in England & Wales. Liver-related mortality in under 65s. Mohammad . Hassabi. (MD). Assistant Professor of Sports and Exercise Med. Dept.. Shahid. . Beheshti. University of Medical Sciences. Taleghani. Medical Center. Physical activity. Exercise. . Sports. Rohit . Pai. MD, FRCPC. Gastroenterology and Hepatology. Island Health and Pacific Digestive Health. Clinical Assistant Professor, UBC. Liver Care Clinic, Royal . Jubillee. Hospital. Disclosures. Research: Intercept. Diabetes. Hypertension. HDL < 1 . mmol. /L . Triglycerides > 1.7 . mmol. /L. Suspicion of NAFLD ?. Remember normal LFT’s do not rule out liver disease Exclude significant alcohol misuse (intermediate or high risk group in the alcohol related liver disease pathway) before diagnosing NAFLD via this pathway. Carolyn Yanavich, . Antônio Pacheco, Sandra . W Cardoso, Estevão Portela, Ursula . B Chaves, Ricardo Santos, . Michelle Morata, . Valdilea . G Veloso, Beatriz . Grinsztejn, . Hugo Perazzo. National Institute of . solution concepts, and . Refinements of NASH Equilibrium. Tuomas Sandholm. The heart of the problem. In a 1-agent setting, agent. ’. s expected utility maximizing strategy is well-defined. But in a multiagent system, the outcome may depend on...